Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820

Showing 26-50 of 820 citing articles:

Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study
Xi Xiong, Carlos King Ho Wong, Ivan Chi Ho Au, et al.
Thyroid (2022) Vol. 32, Iss. 5, pp. 505-514
Open Access | Times Cited: 42
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
Yuntao Zou, Doudou Huang, Qian Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 41
SARS-CoV-2 Infection and Lung Regeneration
Fuxiaonan Zhao, Qingwen Ma, Qing Yue, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 40
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
COVID-19 Vaccines: Current and Future Perspectives
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 608-608
Open Access | Times Cited: 37
COVID-19 Vaccines and Autoimmune Hematologic Disorders
María Eva Mingot‐Castellano, Nora Butta, Mariana Canaro, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 961-961
Open Access | Times Cited: 37
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
Petra Kiszel, Pál Sík, János Miklós, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment
Júlia German-Cortés, Mireia Vilar-Hernández, Diana Rafael, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 831-831
Open Access | Times Cited: 35
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
Joon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102140-102140
Open Access | Times Cited: 27
Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk
Dimitrios Paraskevis, Maria Gkova, Kassiani Μellou, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 12, pp. 1667-1674
Open Access | Times Cited: 26
Impact of Paxlovid on in-hospital outcomes and post-COVID-19 condition in adult patients infected with SARS-CoV-2 Omicron variant: A non-randomized controlled clinical trial
Jianchao Xu, Jinzhong Song, Ziyu Xie, et al.
Medicine (2023) Vol. 102, Iss. 51, pp. e36714-e36714
Open Access | Times Cited: 26
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
Zubair Akhtar, Mallory Trent, Aye Moa, et al.
European Heart Journal Supplements (2023) Vol. 25, Iss. Supplement_A, pp. A42-A49
Open Access | Times Cited: 25
An Overview of the Use of Nanoparticles in Vaccine Development
Daniel Lozano, Vicente Larraga, María Vallet‐Regí, et al.
Nanomaterials (2023) Vol. 13, Iss. 12, pp. 1828-1828
Open Access | Times Cited: 25
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 24
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines
Paulina Kapłonek, Yixiang Deng, Jessica Shih-Lu Lee, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 5, pp. 101048-101048
Open Access | Times Cited: 21
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 9
Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics
Rebecca R. Martin, Allan Maleche, Jill Gay, et al.
BMJ Global Health (2024) Vol. 9, Iss. 1, pp. e013680-e013680
Open Access | Times Cited: 8
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8
Research Progress of Bioactive Components in Sanghuangporus spp.
Jungu Lu, Manman Su, Xuan Zhou, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1195-1195
Open Access | Times Cited: 8
Association of vaccine status, reinfections, and risk factors with Long COVID syndrome
María Elena Romero-Ibarguengoitia, Juan Francisco Rodríguez-Torres, Arnulfo Garza-Silva, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses
Nora Hilda Rosas-Murrieta, Alan Rodríguez-Enríquez, Irma Herrera‐Camacho, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 238-238
Open Access | Times Cited: 7
Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19
Noelia Silva-Pilipich, Uxue Beloki, Laura Salaberry, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 318-318
Open Access | Times Cited: 7
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic
Shigeyoshi Yamanaga, Keita Shimata, Satoko Ohfuji, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 8, pp. 1495-1508
Open Access | Times Cited: 7

Scroll to top